Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Matias-Guiu, X; Selinger, CI; Anderson, L; Buza, N; Ellenson, LH; Fadare, O; Ganesan, R; Ip PPC; Palacios, J; Parra-Herran, C; Raspollini, MR; Soslow, RA; Werner HMJ; Lax, SF; McCluggage, WG

    Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 41 90-118. .

    [doi:10.1097/PGP.0000000000000901]

  • Barcelo, C.; Siso, P.; de la Rosa, I.; Megino-Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet-Llopart, N.; Puig, S.; Matias-Guiu, X.; Marti, R. M.; Macia, A.

    M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.

    BRITISH JOURNAL OF CANCER 127 1142-1152. .

    [doi:10.1038/s41416-022-01886-4]

  • Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ

    CRABP2 - A novel biomarker for high-risk endometrial cancer.

    GYNECOLOGIC ONCOLOGY 167 314-322. .

    [doi:10.1016/j.ygyno.2022.09.020]

  • Vrede SW; Hulsman AMC; Reijnen C; Van de Vijver K; Colas E; Mancebo G; Moiola CP; Gil-Moreno A; Huvila J; Koskas M; Weinberger V; Minar L; Jandakova E; Santacana M; Matias-Guiu X; Amant F; Snijders MPLM; Küsters-Vandevelde HVN; Bulten J; Pijnenborg JMA

    The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.

    GYNECOLOGIC ONCOLOGY 167 196-204. .

    [doi:10.1016/j.ygyno.2022.08.016]

  • Carretero-Barrio I; Lop-Gros J; Iglesias M; Martínez C; Matias-Guiu X; Pérez-Mies B; Palacios J

    Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents.

    VIRCHOWS ARCHIV 481 1-5. .

    [doi:10.1007/s00428-022-03303-w]

  • Ruiz-Mitjana, A; Navaridas, R; Vidal-Sabanes, M; Perramon-Guell, A; Yeramian, A; Felip, I; Eritja, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

    SCIENTIFIC REPORTS 12 14821-14821. .

    [doi:10.1038/s41598-022-18976-1]

  • Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N

    Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

    Cancers 14 -. .

    [doi:10.3390/cancers14122842]

  • Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]

  • Jiménez-Sánchez D; Ariz M; Chang H; Matias-Guiu X; de Andrea CE; Ortiz-de-Solórzano C

    NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.

    MEDICAL IMAGE ANALYSIS 78 102384-102384. .

    [doi:10.1016/j.media.2022.102384]

  • Gatius, S; Velasco, A; Varela, M; Cuatrecasas, M; Jares, P; Setaffy, L; Bonhomme, B; Santon, A; Lindemann, K; Croce, S; Davidson, B; Lax, S; Palacios, J; Matias-Guiu, X

    Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.

    VIRCHOWS ARCHIV 480 1031-1039. .

    [doi:10.1007/s00428-022-03291-x]

  • Garcia-Garcia, Mar; Alvarez Alegret, Ramiro; Perez-Mies, Belen; Iglesias, Mar; Ramon Y Cajal, Santiago; Matias-Guiu, Xavier; Rodriguez Peralto, Jose Luis

    La necesidad de la coordinación técnica en los servicios de Anatomía Patológica. Documento de posicionamiento de la Sociedad Española de Anatomía Patológica.

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 55 122-124. .

    [doi:10.1016/j.patol.2021.11.001]

  • Temprana-Salvador J; López-García P; Castellví Vives J; de Haro L; Ballesta E; Rojas Abusleme M; Arrufat M; Marques F; Casas JR; Gallego C; Pons L; Mate JL; Fernández PL; López-Bonet E; Bosch R; Martínez S; Ramón Y Cajal S; Matias-Guiu X

    DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results.

    Diagnostics 12 -. .

    [doi:10.3390/diagnostics12040852]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment